JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB222320

Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52]

Be the first to review this product! Submit a review

|

(37 Publications)

Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (ab222320) is a rabbit monoclonal antibody detecting RIP3 in Western Blot, Dot Blot. Suitable for Mouse.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 20 publications

View Alternative Names

Rip3, Ripk3, Receptor-interacting serine/threonine-protein kinase 3, RIP-like protein kinase 3, Receptor-interacting protein 3, RIP-3, mRIP3

5 Images
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (AB222320)
  • WB

Supplier Data

Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (AB222320)

Blocking and diluting buffer concentration : 5% NFDM/TBST.

ab181602 GAPDH was used as a loading control at 1/1000000 dilution.

We recommend involving downstream protein p-MLKL as a control to validate the stimulation of p-RIP3.

Lanes 1 - 4:

Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (ab222320) at 1/1000 dilution

Lanes 5 - 8:

Western blot - Anti-MLKL (phospho S345) antibody [EPR9515(2)] (<a href='/en-us/products/primary-antibodies/mlkl-phospho-s345-antibody-epr95152-ab196436'>ab196436</a>) at 1/1000 dilution

Lanes 1, 3, 5 and 7:

Untreated L-929 (mouse connective tissue fibroblast cell line) whole cell lysate at 20 µg

Lanes 2 and 6:

L-929 (mouse connective tissue fibroblast cell line) treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 μM z-VAD for 8 hours whole cell lysate at 20 µg

Lanes 4 and 8:

L-929 (mouse connective tissue fibroblast cell line) treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 μM z-VAD for 6 hours whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 57 kDa,54 kDa

Observed band size: 53 kDa

false

Exposure time: 180s

Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (AB222320)
  • WB

Lab

Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (AB222320)

Blocking/Dilution buffer : 5% NFDM/TBST.

Cells were lysed in 4% SDS buffer (4% SDS,10% 2-ME, 20% glycerol, 0.004% Bromophenol blue, Tris-HCl).

The images were kindly provided by our collaborator Dr. Jiahuai Han, Xiamen University.

All lanes:

Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (ab222320) at 1/500 dilution

Lane 1:

Untreated L-929 (mouse connective tissue fibroblast cell line) whole cell lysate at 20 µg

Lane 2:

L-929 (mouse connective tissue fibroblast cell line) whole cell lysate treated with 10 ng/ml TNF-a and 20 µM z-VAD for 2 hours at 20 µg

Lane 3:

L-929 (mouse connective tissue fibroblast cell line) whole cell lysate treated with 10 ng/ml TNF-a and 20 µM z-VAD for 3.5 hours at 20 µg

Lane 4:

L-929 (mouse connective tissue fibroblast cell line) whole cell lysate treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 µM z-VAD for 6 hours at 20 µg

Lane 5:

L-929 (mouse connective tissue fibroblast cell line) whole cell lysate with RIP3 KO cells treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 µM z-VAD for 6 hours at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/5000 dilution

Predicted band size: 57 kDa

false

Exposure time: 60s

Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (AB222320)
  • WB

Lab

Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (AB222320)

Blocking/Dilution buffer : 5% NFDM/TBST.

The higher MW bands in Lanes 1 and 2 are extra bands.

The lysates were prepared following the 1% SDS Hot Lysate buffer method.

For Lysate preparation protocol, please refer to the protocol section of the website and/or here.

All lanes:

Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (ab222320) at 1/1000 dilution

Lane 1:

Untreated L-929 (mouse connective tissue fibroblast cell line) whole cell lysate at 10 µg

Lane 2:

L-929 (mouse connective tissue fibroblast cell line) whole cell lysate treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 µM z-VAD for 6 hours at 10 µg

Lane 3:

L-929 (mouse connective tissue fibroblast cell line) whole cell lysate treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 µM z-VAD for 6 hours, then treated with alkaline phosphatase for 1 hour at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 57 kDa

Observed band size: 53 kDa

false

Exposure time: 30s

Dot Blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (AB222320)
  • Dot

Lab

Dot Blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (AB222320)

Dot blot analysis of RIP3 (phospho T231 + S232) labeled with ab222320 at 1/1000 dilution.

Lane 1 : RIP3 (phospho T231 + S232) peptide (aa229-239);

Lane 2 : RIP3 (phospho T231 + S232) peptide (aa223-236);

Lane 3 : RIP3 (phospho T231) peptide (aa223-239);

Lane 4 : RIP3 (phospho S232) peptide (aa223-239);

Lane 5 : RIP3 non-phospho peptide (aa223-239).

Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution was used as secondary antibody.

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure time : 3 minutes.

Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (AB222320)
  • WB

CiteAb

Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (AB222320)

RIP3 (phospho T231 + S232) western blot using anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] ab222320. Publication image and figure legend from Jiao, J., Wang, Y., et al., 2020, Front Pharmacol, PubMed 31998134.

ab222320 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab222320 please see the product overview.

NSA suppresses MLKL activation but not p-RIP3. Prevention of MLKL activation by treatment with 3 μM NSA for 24 h after OGD treatment. (A) NeuN and p-MLKL double staining. Cell nuclei were stained with DAPI (blue fluorescence) and neurons were stained with NeuN (red fluorescence). Pictures were taken using a fluorescence microscope (scale bar = 20 μm). (B) WB analysis of the level of p-RIP3 and p-MLKL induced by OGD, p-MLKL level was significantly reversed after NSA treatment. Data are presented as the mean ± SEM, n = 4. *p < 0.05, vs. the control group (CTL). #p < 0.05, vs. the OGD group. Data were analyzed using Student's t-test. RIP3, receptor interacting protein kinase-3; OGD, oxygen-glucose deprivation; NSA, necrosulfonamide; MLKL, mixed-lineage kinase domain-like protein; Nec-1, necrostatin-1; WB, Western blot.

false

  • Carrier free

    Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR19403-52

Isotype

IgG

Carrier free

No

Reacts with

Mouse

Applications

Dot, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "Dot" : {"fullname" : "Dot Blot", "shortname":"Dot"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Synthetic peptide": { "Dot-species-checked": "testedAndGuaranteed", "Dot-species-dilution-info": "1/1000", "Dot-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Product details

What is this antibody validated in?
Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (ab222320) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Dot Blot in Mouse samples.

What is the molecular weight of RIP3?
Anti-RIP3 (phospho T231 + S232) [EPR19403-52] (ab222320) specifically detects a band for RIP3 (UniProt: Q9QZL0) at a molecular weight of 57kDa.

Trusted by the scientific community
Anti-RIP3 (phospho T231 + S232) [EPR19403-52] (ab222320) was first used in a scientific publication in 2017 and has been cited over 20 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (ab222320) has been confirmed by Western blot testing in RIP3 Knockout L-929 cell line.

Other related products
We have a range of other formats of antibody clone [EPR19403-52] also available for your convenience: ab222320, Carrier free - ab240399

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

'Receptor-interacting protein kinase 3' (RIP3) also known as RIPK3 is a serine/threonine-protein kinase with a molecular weight of approximately 57 kDa. Mechanically it contains a kinase domain that allows it to phosphorylate specific substrates which is important for mediating its function within the cell. RIP3 is expressed in various tissues with notable presence in the spleen heart and adipose tissue. The protein localizes predominantly in the cytoplasm where it interacts with other cellular proteins to initiate downstream signaling events.
Biological function summary

RIP3 facilitates the execution of necroptosis a form of programmed cell death distinct from apoptosis. It becomes activated upon binding with RIP1 forming a necrosome complex that is essential for this pathway. This complex promotes phosphorylation events that subsequently lead to membrane rupture and cell death. Apart from its role in necroptosis RIP3 also engages in metabolic regulation processes linking energy status and cell death under conditions of stress.

Pathways

RIP3 is a principal component of the necroptotic pathway interacting closely with RIP1 to trigger cell death in conditions where caspase activation is inhibited. Alternatively it integrates into metabolic pathways participating in sensing and responding to changes in cellular energy states. The interplay between RIP3 and RIP1 within these pathways illustrates their shared involvement in maintaining cellular homeostasis and triggering cell death when necessary.

RIP3 has significant implications for conditions involving excessive or dysfunctional cell death such as inflammatory diseases and reperfusion injury. The necroptotic activity of RIP3 can exacerbate inflammation by promoting the release of pro-inflammatory factors upon cell death. Furthermore during ischemia-reperfusion injury increased RIP3 activity in conjunction with MLKL another necroptosis-associated protein contributes to tissue damage highlighting its potential as a therapeutic target for reducing cell death-related tissue damage.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine-protein kinase that activates necroptosis and apoptosis, two parallel forms of cell death (PubMed : 27321907, PubMed : 27746097, PubMed : 27917412, PubMed : 28607035, PubMed : 32200799, PubMed : 32296175). Necroptosis, a programmed cell death process in response to death-inducing TNF family members, is triggered by RIPK3 following activation by ZBP1 (PubMed : 19590578, PubMed : 22423968, PubMed : 24012422, PubMed : 24019532, PubMed : 24095729, PubMed : 24557836, PubMed : 27321907, PubMed : 27746097, PubMed : 27819681, PubMed : 27819682, PubMed : 32200799, PubMed : 32296175). Activated RIPK3 forms a necrosis-inducing complex and mediates phosphorylation of MLKL, promoting MLKL localization to the plasma membrane and execution of programmed necrosis characterized by calcium influx and plasma membrane damage (PubMed : 24813849, PubMed : 24813850, PubMed : 27321907). In addition to TNF-induced necroptosis, necroptosis can also take place in the nucleus in response to orthomyxoviruses infection : following ZBP1 activation, which senses double-stranded Z-RNA structures, nuclear RIPK3 catalyzes phosphorylation and activation of MLKL, promoting disruption of the nuclear envelope and leakage of cellular DNA into the cytosol (PubMed : 32200799, PubMed : 32296175). Also regulates apoptosis : apoptosis depends on RIPK1, FADD and CASP8, and is independent of MLKL and RIPK3 kinase activity (PubMed : 27321907). Phosphorylates RIPK1 : RIPK1 and RIPK3 undergo reciprocal auto- and trans-phosphorylation (By similarity). In some cell types, also able to restrict viral replication by promoting cell death-independent responses (PubMed : 30635240). In response to flavivirus infection in neurons, promotes a cell death-independent pathway that restricts viral replication : together with ZBP1, promotes a death-independent transcriptional program that modifies the cellular metabolism via up-regulation expression of the enzyme ACOD1/IRG1 and production of the metabolite itaconate (PubMed : 30635240). Itaconate inhibits the activity of succinate dehydrogenase, generating a metabolic state in neurons that suppresses replication of viral genomes (PubMed : 30635240). RIPK3 binds to and enhances the activity of three metabolic enzymes : GLUL, GLUD1, and PYGL (By similarity). These metabolic enzymes may eventually stimulate the tricarboxylic acid cycle and oxidative phosphorylation, which could result in enhanced ROS production (By similarity).
See full target information Ripk3 pS232 + T231

Publications (37)

Recent publications for all applications. Explore the full list and refine your search

Bioactive materials 53:737-753 PubMed40801020

2025

Inhibition of ARH2 by pH/ROS-responsive nanosystem for improved lung adenocarcinoma immunochemotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Rui Cai,Meng Wang,Mengting Pan,Zhiwu Zhang,Qiang Jia,Longbao Feng,Zhongjian Yu,Lu Liu,Tongyu Zhu,Silin Cai,Han Tian,Jiangyu Zhang,Rui Guo,Yanfang Zheng

Nature communications 16:4288 PubMed40341069

2025

Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.

Applications

Unspecified application

Species

Unspecified reactive species

Haixia Su,Guofeng Chen,Hang Xie,Wanchen Li,Muya Xiong,Jian He,Hangchen Hu,Wenfeng Zhao,Qiang Shao,Minjun Li,Qiang Zhao,Yechun Xu

Current research in microbial sciences 7:100318 PubMed39726972

2024

An intracellular bacterial pathogen triggers RIG-I/MDA5-dependent necroptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Hang Xu,Huili Li,Boguang Sun,Li Sun

Oncology letters 28:529 PubMed39290957

2024

Zinc finger domain of p62/SQSTM1 is involved in the necroptosis of human cisplatin‑resistant ovarian cancer cells treated with sulfasalazine.

Applications

Unspecified application

Species

Unspecified reactive species

Nannan Liu,Shanshan Liu,Xueshuang Zhang,Wenzhu Tian,Heqiang Jia,Xin Ye,Xiaoyu Yan,Chunyan Yu,Huimei Yu

Journal of virology 98:e0126224 PubMed39194237

2024

Protective role of cytosolic prion protein against virus infection in prion-infected cells.

Applications

Unspecified application

Species

Unspecified reactive species

Hideyuki Hara,Junji Chida,Batzaya Batchuluun,Etsuhisa Takahashi,Hiroshi Kido,Suehiro Sakaguchi

Journal of nanobiotechnology 22:355 PubMed38902678

2024

NIR-responsive CN-Pt-GEM hydrogel induces necroptosis and immunotherapeutic responses prevent postoperative recurrence and wound infection in lung carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Meng Wang,Rui Cai,Zhiwu Zhang,Longbao Feng,Ziying Lei,Fengpin Wang,Zhongjian Yu,Lu Liu,Xia Yang,Huili Guo,Bingjie Shan,Shiting Xu,Rui Guo,Shuzhong Cui,Yanfang Zheng

British journal of pharmacology 181:2443-2458 PubMed38555910

2024

Identification of a marine-derived sesquiterpenoid, Compound-8, that inhibits tumour necrosis factor-induced cell death by blocking complex II assembly.

Applications

Unspecified application

Species

Unspecified reactive species

Yuan He,Tingting Yang,Jiao Li,Kaiying Li,Chunlin Zhuang,Meng Zhang,Ran Li,Yaxing Zhao,Qianqian Song,Mengyuan Jiang,Shuichun Mao,Xin-Gang Song,Yufeng Guo,Xuran Li,Fei Tan,Siriporn Jitkaew,Wen Zhang,Zhenyu Cai

EMBO reports 25:2278-2305 PubMed38499808

2024

SorLA restricts TNFα release from microglia to shape a glioma-supportive brain microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Paulina Kaminska,Peter L Ovesen,Mateusz Jakiel,Tomasz Obrebski,Vanessa Schmidt,Michal Draminski,Aleksandra G Bilska,Magdalena Bieniek,Jasper Anink,Bohdan Paterczyk,Anne Mette Gissel Jensen,Sylwia Piatek,Olav M Andersen,Eleonora Aronica,Thomas E Willnow,Bozena Kaminska,Michal J Dabrowski,Anna R Malik

Cell death & disease 14:663 PubMed37816709

2023

Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury.

Applications

Unspecified application

Species

Unspecified reactive species

Wenjia Xie,Qingyun He,Yan Zhang,Xinxin Xu,Ping Wen,Hongdi Cao,Yang Zhou,Jing Luo,Junwei Yang,Lei Jiang

Cell death discovery 9:363 PubMed37777514

2023

Activation of AMPK ameliorates acute severe pancreatitis by suppressing pancreatic acinar cell necroptosis in obese mice models.

Applications

Unspecified application

Species

Unspecified reactive species

Kunlei Wang,Anbang Zhao,Dilinigeer Tayier,Kai Tan,Wenjing Song,Qian Cheng,Xinyin Li,Zhinan Chen,Qifeng Wei,Yufeng Yuan,Zhiyong Yang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com